Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology | Obstetrics/Gynecology
Disease Category: Urinary Incontinence
Trial Information
A Double-Blind, Randomized, Parallel, Placebo-Controlled, Multicenter Study Evaluating the Effect of Treatment with Topically Administered Oxybutynin Gel in Patients with Urinary Frequency, and Urge and Mixed Urinary Incontinence with a Predominance of Urge Incontinence Episodes.
Oxybutynin is a drug used for the treatment of OAB with symptoms of urge urinary incontinence. Oral and transdermal (patch) formulations of oxybutynin have previously been evaluated in clinical research studies and approved, but, to date, there have not been any clinical research studies evaluating a gel formulation of oxybutynin.
Patient Inclusion Criteria: Must be 18 years of age and have over active bladder symptoms for at least 3 months.
Patient Exclusion Criteria: Known allergy to oxybutynin.
Carolinas Research Associates
4315 Physicians Blvd.
Harrisburg, NC 28075
Phone: 704-366-3001
EMail: contact@carolinasresearch.com
View Google Map
Research Center Information: Carolinas Research Associates
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
